25 XP   0   0   10

Avadel Pharmaceuticals PLC
Buy, Hold or Sell?

Let's analyse Avadel together

PenkeI guess you are interested in Avadel Pharmaceuticals PLC. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Avadel Pharmaceuticals PLC. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Avadel Pharmaceuticals PLC

I send you an email if I find something interesting about Avadel Pharmaceuticals PLC.

Quick analysis of Avadel (30 sec.)










What can you expect buying and holding a share of Avadel? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.5%

What is your share worth?

Current worth
$1.23
Expected worth in 1 year
$2.60
How sure are you?
27.5%

+ What do you gain per year?

Total Gains per Share
$1.37
Return On Investment
11.9%

For what price can you sell your share?

Current Price per Share
$11.48
Expected price per share
$8 - $12.57
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Avadel (5 min.)




Live pricePrice per Share (EOD)

$11.48

Intrinsic Value Per Share

$-22.13 - $-11.25

Total Value Per Share

$-20.90 - $-10.02

2. Growth of Avadel (5 min.)




Is Avadel growing?

Current yearPrevious yearGrowGrow %
How rich?$110.1m$29.4m$19m39.3%

How much money is Avadel making?

Current yearPrevious yearGrowGrow %
Making money-$39.7m-$33m-$6.6m-16.8%
Net Profit Margin-1,206.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Avadel (5 min.)




3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Avadel? (5 min.)

Welcome investor! Avadel's management wants to use your money to grow the business. In return you get a share of Avadel.

What can you expect buying and holding a share of Avadel?

First you should know what it really means to hold a share of Avadel. And how you can make/lose money.

Speculation

The Price per Share of Avadel is $11.48. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Avadel.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Avadel, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.23. Based on the TTM, the Book Value Change Per Share is $0.34 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.31 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Avadel.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.41-3.5%-0.44-3.9%-0.37-3.2%-0.24-2.1%-0.14-1.2%
Usd Book Value Change Per Share-0.37-3.2%0.343.0%-0.31-2.7%0.020.2%0.040.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.010.1%0.010.0%
Usd Total Gains Per Share-0.37-3.2%0.343.0%-0.31-2.7%0.040.3%0.040.4%
Usd Price Per Share10.30-10.78-5.59-6.87-9.37-
Price to Earnings Ratio-6.34--6.13--5.07--19.13--10.69-
Price-to-Total Gains Ratio-27.84--35.33--28.57--42.30--20.09-
Price to Book Ratio8.36--8.27--20.29--2.20-8.73-
Price-to-Total Gains Ratio-27.84--35.33--28.57--42.30--20.09-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share11.48
Number of shares87
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.340.02
Usd Total Gains Per Share0.340.04
Gains per Quarter (87 shares)29.833.06
Gains per Year (87 shares)119.3312.25
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10119109492
2023922871714
30358347112626
40477466143538
50597585184350
60716704225262
70835823256174
80955942296986
9010741061327898
100119311803686110

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%9.031.00.022.5%25.070.00.026.3%
Book Value Change Per Share1.03.00.025.0%1.011.00.08.3%3.017.00.015.0%11.025.04.027.5%27.050.018.028.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%1.00.019.05.0%1.00.039.02.5%1.00.094.01.1%
Total Gains per Share1.03.00.025.0%1.011.00.08.3%3.017.00.015.0%11.025.04.027.5%27.050.018.028.4%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Avadel

About Avadel Pharmaceuticals PLC

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

Fundamental data was last updated by Penke on 2023-11-10 07:36:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Avadel Pharmaceuticals PLC.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Avadel earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Avadel to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -517.2% means that $-5.17 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Avadel Pharmaceuticals PLC:

  • The MRQ is -517.2%. The company is making a huge loss. -2
  • The TTM is -1,206.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-517.2%TTM-1,206.0%+688.9%
TTM-1,206.0%YOY--1,206.0%
TTM-1,206.0%5Y-256.4%-949.6%
5Y-256.4%10Y-116.0%-140.4%
1.1.2. Return on Assets

Shows how efficient Avadel is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Avadel to the Drug Manufacturers - Specialty & Generic industry mean.
  • -17.9% Return on Assets means that Avadel generated $-0.18 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Avadel Pharmaceuticals PLC:

  • The MRQ is -17.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -23.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.9%TTM-23.1%+5.3%
TTM-23.1%YOY-18.7%-4.4%
TTM-23.1%5Y-12.0%-11.1%
5Y-12.0%10Y-5.9%-6.1%
1.1.3. Return on Equity

Shows how efficient Avadel is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Avadel to the Drug Manufacturers - Specialty & Generic industry mean.
  • -32.9% Return on Equity means Avadel generated $-0.33 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Avadel Pharmaceuticals PLC:

  • The MRQ is -32.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -19.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-32.9%TTM-19.5%-13.4%
TTM-19.5%YOY-19.1%-0.4%
TTM-19.5%5Y-125.0%+105.5%
5Y-125.0%10Y-73.4%-51.5%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Avadel Pharmaceuticals PLC.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Avadel is operating .

  • Measures how much profit Avadel makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Avadel to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Avadel Pharmaceuticals PLC:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-827.9%+827.9%
TTM-827.9%YOY--827.9%
TTM-827.9%5Y-183.9%-644.0%
5Y-183.9%10Y-88.9%-95.0%
1.2.2. Operating Ratio

Measures how efficient Avadel is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 6.01 means that the operating costs are $6.01 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Avadel Pharmaceuticals PLC:

  • The MRQ is 6.006. The company is inefficient in keeping operating costs low. -1
  • The TTM is 10.030. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ6.006TTM10.030-4.025
TTM10.030YOY-+10.030
TTM10.0305Y2.550+7.481
5Y2.55010Y1.739+0.810
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Avadel Pharmaceuticals PLC.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Avadel is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.19 means the company has $3.19 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Avadel Pharmaceuticals PLC:

  • The MRQ is 3.187. The company is very able to pay all its short-term debts. +2
  • The TTM is 2.425. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ3.187TTM2.425+0.762
TTM2.425YOY4.566-2.142
TTM2.4255Y6.944-4.520
5Y6.94410Y4.594+2.350
1.3.2. Quick Ratio

Measures if Avadel is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Avadel to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 4.82 means the company can pay off $4.82 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Avadel Pharmaceuticals PLC:

  • The MRQ is 4.825. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.459. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.825TTM3.459+1.366
TTM3.459YOY6.261-2.802
TTM3.4595Y10.400-6.941
5Y10.40010Y6.878+3.522
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Avadel Pharmaceuticals PLC.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Avadel assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Avadel to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.46 means that Avadel assets are financed with 45.8% credit (debt) and the remaining percentage (100% - 45.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Avadel Pharmaceuticals PLC:

  • The MRQ is 0.458. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.794. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.458TTM0.794-0.336
TTM0.794YOY0.885-0.091
TTM0.7945Y0.812-0.018
5Y0.81210Y0.807+0.005
1.4.2. Debt to Equity Ratio

Measures if Avadel is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Avadel to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 84.4% means that company has $0.84 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Avadel Pharmaceuticals PLC:

  • The MRQ is 0.844. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.312. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.844TTM0.312+0.532
TTM0.312YOY1.291-0.979
TTM0.3125Y4.312-4.000
5Y4.31210Y4.150+0.162
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Avadel Pharmaceuticals PLC

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Avadel generates.

  • Above 15 is considered overpriced but always compare Avadel to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -6.34 means the investor is paying $-6.34 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Avadel Pharmaceuticals PLC:

  • The EOD is -7.072. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.345. Based on the earnings, the company is expensive. -2
  • The TTM is -6.134. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.072MRQ-6.345-0.727
MRQ-6.345TTM-6.134-0.211
TTM-6.134YOY-5.071-1.062
TTM-6.1345Y-19.126+12.992
5Y-19.12610Y-10.693-8.432
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Avadel Pharmaceuticals PLC:

  • The EOD is -6.711. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.021. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.559. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.711MRQ-6.021-0.690
MRQ-6.021TTM-8.559+2.538
TTM-8.559YOY-7.815-0.744
TTM-8.5595Y-11.898+3.339
5Y-11.89810Y-8.663-3.234
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Avadel is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Avadel Pharmaceuticals PLC:

  • The EOD is 9.315. Based on the equity, the company is overpriced. -1
  • The MRQ is 8.358. Based on the equity, the company is overpriced. -1
  • The TTM is -8.267. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD9.315MRQ8.358+0.958
MRQ8.358TTM-8.267+16.625
TTM-8.267YOY-20.289+12.022
TTM-8.2675Y-2.195-6.071
5Y-2.19510Y8.733-10.928
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Avadel Pharmaceuticals PLC.

3.1. Institutions holding Avadel Pharmaceuticals PLC

Institutions are holding 63.74% of the shares of Avadel Pharmaceuticals PLC.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-06-30HHG PLC8.41750.0771752254569575810.1916
2023-06-30RTW INVESTMENTS, LLC7.62092.13686810641106870218.6122
2023-06-30Gendell Jeffrey L6.0386.89565396060941461.7757
2023-06-30Polar Capital Holdings PLC5.07440.51554534921-37569-0.8216
2023-06-30Vivo Capital, LLC4.28524.35613829577681391.8115
2023-06-30Adage Capital Partners Gp LLC2.99880.096268000026800000
2023-06-30COWEN AND COMPANY, LLC2.9813.63912664076-1068702-28.6302
2023-09-30WEALTH EFFECTS LLC2.695912.25422409289402001.6969
2023-06-30Woodline Partners LP2.10290.3671187934300
2023-06-30Brandes Investment Partners & Co1.44260.4281289195-155440-10.7598
2023-06-30Tri Locum Partners LP1.16316.36661039474-287623-21.6731
2023-06-30Samsara BioCapital, LLC1.08262.7987967527-441882-31.3523
2023-06-30D. E. Shaw & Co LP0.85690.0129765836454546146.0201
2023-06-30Renaissance Technologies Corp0.77440.0164692106-127648-15.5715
2023-06-30Point72 Asset Management, L.P.0.75670.033167626022026048.3026
2023-06-30Marshall Wace Asset Management Ltd0.68150.019660902630115197.816
2023-06-30Modera Wealth Management, LLC0.66470.177759400000
2023-06-30Knoll Capital Management LP0.55959.98915000005000000
2023-06-30First Republic Inv Mgmt Inc0.55950.04285000005000000
2023-06-30Citadel Advisors Llc0.5440.001748619516771452.6606
Total 51.300150.224145846071+4671752+10.2%

3.2. Funds holding Avadel Pharmaceuticals PLC

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Polar Capital Healthcare Opports Inc3.98632.4471356249000
2023-09-30Janus Henderson Global Life Sciences D3.26760.6512920198100107952.1635
2023-09-30Janus Henderson Glb Life Scn I2 USD2.52880.65672259961374731.6861
2023-06-30Janus Henderson Global Life Sciences2.14740.653191911924634114.7265
2023-06-30Janus Selection Global Life Science AUSD1.69450.654151431315331211.2647
2023-09-30Janus Henderson Venture D1.22830.39981097702772874237.9333
2023-09-30Janus Henderson Hrzn Biotec E2 USD0.43732.5702390832-46215-10.5744
2023-06-30PSI Polar Capital Fut Hlthcr I USD Acc0.40843.54273650003650000
2023-09-30Kennedy Extended Small Cap0.39220.25223505384312714.0291
2023-06-30Janus Henderson US Small Cap Growth0.36350.17253248283248280
2023-09-30DWS Small Cap Core S0.33570.51233000007500033.3333
2023-10-31MM Access II Fut of Earth USD F Acc0.23550.387521047400
2023-09-30Brandes International Small Cap Eq0.22280.509519912100
2023-09-30Kennedy Small Cap Growth0.18730.39831674151674150
2023-09-30Kennedy Small Cap Select0.18690.85731670584506836.944
2023-09-30Brandes International Small Cap Equity A0.1760.484915730500
2023-09-30DWS ESG Biotech LC0.15670.432914000300
2023-09-30Brandes Global Small Cap Equity Cl F0.15070.486313471100
2023-09-30Brandes European Value I USD0.1250.274211175100
2023-06-30Empower Small Cap Value/Kennedy SP0.12120.337510827181698.1607
Total 18.352116.679916401090+3193471+19.5%

3.3. Insider Transactions

Insiders are holding 4.976% of the shares of Avadel Pharmaceuticals PLC.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-08-14Thomas S MchughBUY200014.45
2023-08-10Geoffrey Michael GlassBUY1400013.4
2023-08-10Gregory J DivisBUY1000013.2
2023-05-09Linda PalczukBUY250014.76
2022-12-23Linda PalczukBUY20007.2
2022-11-29Thomas S MchughBUY50007.8
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Avadel Pharmaceuticals PLC compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.3700.343-208%-0.312-16%0.025-1589%0.035-1153%
Book Value Per Share--1.2320.543+127%0.329+274%0.634+94%0.588+109%
Current Ratio--3.1872.425+31%4.566-30%6.944-54%4.594-31%
Debt To Asset Ratio--0.4580.794-42%0.885-48%0.812-44%0.807-43%
Debt To Equity Ratio--0.8440.312+171%1.291-35%4.312-80%4.150-80%
Dividend Per Share----0%-0%0.010-100%0.005-100%
Eps---0.406-0.445+10%-0.370-9%-0.244-40%-0.141-65%
Free Cash Flow Per Share---0.428-0.326-24%-0.219-49%-0.202-53%-0.120-72%
Free Cash Flow To Equity Per Share---0.0870.130-167%-0.196+125%-0.006-94%0.005-1737%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.000+0%
Intrinsic Value_10Y_max---11.249--------
Intrinsic Value_10Y_min---22.131--------
Intrinsic Value_1Y_max---0.574--------
Intrinsic Value_1Y_min---1.217--------
Intrinsic Value_3Y_max---2.146--------
Intrinsic Value_3Y_min---4.544--------
Intrinsic Value_5Y_max---4.226--------
Intrinsic Value_5Y_min---8.820--------
Market Cap1025944640.000+10%920614000.000962971100.000-4%499567120.000+84%613919656.000+50%837291882.000+10%
Net Profit Margin---5.172-12.060+133%--100%-2.564-50%-1.160-78%
Operating Margin----8.2790%-0%-1.8390%-0.8890%
Operating Ratio--6.00610.030-40%-+100%2.550+136%1.739+245%
Pb Ratio9.315+10%8.358-8.267+199%-20.289+343%-2.195+126%8.733-4%
Pe Ratio-7.072-11%-6.345-6.134-3%-5.071-20%-19.126+201%-10.693+69%
Price Per Share11.480+10%10.30010.775-4%5.590+84%6.870+50%9.369+10%
Price To Free Cash Flow Ratio-6.711-11%-6.021-8.559+42%-7.815+30%-11.898+98%-8.663+44%
Price To Total Gains Ratio-31.035-11%-27.845-35.331+27%-28.567+3%-42.302+52%-20.091-28%
Quick Ratio--4.8253.459+39%6.261-23%10.400-54%6.878-30%
Return On Assets---0.179-0.231+29%-0.187+5%-0.120-33%-0.059-67%
Return On Equity---0.329-0.195-41%-0.191-42%-1.250+279%-0.734+123%
Total Gains Per Share---0.3700.343-208%-0.312-16%0.035-1151%0.040-1018%
Usd Book Value--110149000.00048507500.000+127%29426000.000+274%56649600.000+94%52572450.000+110%
Usd Book Value Change Per Share---0.3700.343-208%-0.312-16%0.025-1589%0.035-1153%
Usd Book Value Per Share--1.2320.543+127%0.329+274%0.634+94%0.588+109%
Usd Dividend Per Share----0%-0%0.010-100%0.005-100%
Usd Eps---0.406-0.445+10%-0.370-9%-0.244-40%-0.141-65%
Usd Free Cash Flow---38226000.000-29141000.000-24%-19540000.000-49%-18063800.000-53%-10707225.000-72%
Usd Free Cash Flow Per Share---0.428-0.326-24%-0.219-49%-0.202-53%-0.120-72%
Usd Free Cash Flow To Equity Per Share---0.0870.130-167%-0.196+125%-0.006-94%0.005-1737%
Usd Market Cap1025944640.000+10%920614000.000962971100.000-4%499567120.000+84%613919656.000+50%837291882.000+10%
Usd Price Per Share11.480+10%10.30010.775-4%5.590+84%6.870+50%9.369+10%
Usd Profit---36274000.000-39735000.000+10%-33078750.000-9%-21817000.000-40%-10202700.000-72%
Usd Revenue--7014000.0002127500.000+230%-+100%6260400.000+12%17165675.000-59%
Usd Total Gains Per Share---0.3700.343-208%-0.312-16%0.035-1151%0.040-1018%
 EOD+5 -3MRQTTM+16 -16YOY+14 -185Y+11 -2310Y+11 -24

4.2. Fundamental Score

Let's check the fundamental score of Avadel Pharmaceuticals PLC based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.072
Price to Book Ratio (EOD)Between0-19.315
Net Profit Margin (MRQ)Greater than0-5.172
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.825
Current Ratio (MRQ)Greater than13.187
Debt to Asset Ratio (MRQ)Less than10.458
Debt to Equity Ratio (MRQ)Less than10.844
Return on Equity (MRQ)Greater than0.15-0.329
Return on Assets (MRQ)Greater than0.05-0.179
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Avadel Pharmaceuticals PLC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.258
Ma 20Greater thanMa 5010.948
Ma 50Greater thanMa 10010.763
Ma 100Greater thanMa 20012.229
OpenGreater thanClose11.810
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Interest Expense  3,564-3093,25543,259-9642,295-4,273-1,978



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets203,100
Total Liabilities92,951
Total Stockholder Equity110,149
 As reported
Total Liabilities 92,951
Total Stockholder Equity+ 110,149
Total Assets = 203,100

Assets

Total Assets203,100
Total Current Assets172,255
Long-term Assets172,255
Total Current Assets
Cash And Cash Equivalents 51,811
Short-term Investments 101,368
Net Receivables 6,239
Inventory 5,286
Other Current Assets 7,551
Total Current Assets  (as reported)172,255
Total Current Assets  (calculated)172,255
+/-0
Long-term Assets
Property Plant Equipment 3,452
Goodwill 16,836
Long-term Assets Other 10,557
Long-term Assets  (as reported)30,845
Long-term Assets  (calculated)30,845
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities54,054
Long-term Liabilities38,897
Total Stockholder Equity110,149
Total Current Liabilities
Short-term Debt 22,103
Short Long Term Debt 21,187
Accounts payable 13,263
Other Current Liabilities 18,688
Total Current Liabilities  (as reported)54,054
Total Current Liabilities  (calculated)75,241
+/- 21,187
Long-term Liabilities
Capital Lease Obligations 2,844
Long-term Liabilities Other 36,969
Long-term Liabilities  (as reported)38,897
Long-term Liabilities  (calculated)39,813
+/- 916
Total Stockholder Equity
Common Stock893
Retained Earnings -716,710
Accumulated Other Comprehensive Income -25,951
Other Stockholders Equity 851,917
Total Stockholder Equity (as reported)110,149
Total Stockholder Equity (calculated)110,149
+/-0
Other
Capital Stock945
Cash and Short Term Investments 153,179
Common Stock Shares Outstanding 89,380
Liabilities and Stockholders Equity 203,100
Net Debt -27,780
Net Invested Capital 131,284
Net Working Capital 118,201
Short Long Term Debt Total 24,031



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-31
> Total Assets 
4,700
0
0
29,900
0
0
0
21,500
18,900
0
0
25,318
0
0
0
14,920
12,865
23,131
20,531
20,360
17,376
0
15,598
18,144
18,144
0
21,674
23,076
23,076
23,856
33,022
127,252
127,252
124,230
124,230
145,608
145,608
142,585
127,972
124,351
124,351
113,648
111,262
114,894
114,894
106,435
103,911
101,401
101,401
101,091
88,767
91,861
91,861
93,253
97,921
94,296
94,296
70,480
77,384
74,614
74,614
76,114
72,697
69,402
69,402
133,715
0
117,311
117,311
118,408
116,514
116,252
116,252
174,631
164,385
174,207
174,207
186,546
0
214,977
214,977
249,013
247,985
245,482
258,688
259,160
277,427
252,106
351,861
295,236
269,006
190,300
173,622
165,709
155,888
151,436
207,725
341,401
327,635
311,637
292,941
282,591
264,089
247,265
221,127
157,938
145,758
132,785
140,739
200,976
203,100
203,100200,976140,739132,785145,758157,938221,127247,265264,089282,591292,941311,637327,635341,401207,725151,436155,888165,709173,622190,300269,006295,236351,861252,106277,427259,160258,688245,482247,985249,013214,977214,9770186,546174,207174,207164,385174,631116,252116,252116,514118,408117,311117,3110133,71569,40269,40272,69776,11474,61474,61477,38470,48094,29694,29697,92193,25391,86191,86188,767101,091101,401101,401103,911106,435114,894114,894111,262113,648124,351124,351127,972142,585145,608145,608124,230124,230127,252127,25233,02223,85623,07623,07621,674018,14418,14415,598017,37620,36020,53123,13112,86514,92000025,3180018,90021,50000029,900004,700
   > Total Current Assets 
2,500
0
0
17,800
0
0
0
14,600
11,800
0
0
16,436
0
0
0
7,752
0
0
0
14,061
0
0
0
13,799
13,799
0
18,256
18,711
18,711
19,662
28,588
120,735
120,735
111,066
111,066
120,772
120,772
116,786
101,604
91,988
91,988
80,037
78,750
76,779
76,779
62,668
61,605
56,110
56,110
52,265
49,601
59,189
59,189
59,002
69,239
66,841
66,841
47,223
50,246
45,362
45,362
41,989
40,023
36,652
36,652
30,282
0
25,085
25,085
34,949
32,931
33,623
33,623
105,121
99,248
112,322
112,322
132,167
0
166,306
166,306
177,648
177,854
181,186
204,612
204,351
148,933
123,954
231,933
174,976
147,876
124,851
102,437
97,200
88,602
82,380
130,975
277,019
281,688
263,454
242,314
230,702
205,820
192,490
160,741
125,713
113,222
100,843
109,470
171,230
172,255
172,255171,230109,470100,843113,222125,713160,741192,490205,820230,702242,314263,454281,688277,019130,97582,38088,60297,200102,437124,851147,876174,976231,933123,954148,933204,351204,612181,186177,854177,648166,306166,3060132,167112,322112,32299,248105,12133,62333,62332,93134,94925,08525,085030,28236,65236,65240,02341,98945,36245,36250,24647,22366,84166,84169,23959,00259,18959,18949,60152,26556,11056,11061,60562,66876,77976,77978,75080,03791,98891,988101,604116,786120,772120,772111,066111,066120,735120,73528,58819,66218,71118,71118,256013,79913,79900014,0610007,75200016,4360011,80014,60000017,800002,500
       Cash And Cash Equivalents 
1,200
0
0
15,500
0
0
0
3,800
6,000
0
0
7,277
0
0
0
5,210
0
0
0
10,137
0
0
0
5,309
5,309
0
14,623
14,527
14,527
11,649
22,076
109,617
109,617
100,850
100,850
4,591
4,591
914
1,606
1,018
1,018
5,544
564
51,827
51,827
36,820
29,538
26,313
26,313
22,701
28,405
27,021
27,021
7,205
4,784
8,716
8,716
3,570
3,909
8,184
8,184
11,584
6,729
3,456
3,456
4,755
0
2,742
2,742
8,336
7,807
6,636
6,636
54,104
24,006
39,760
39,760
55,236
0
65,064
65,064
23,899
18,780
39,215
32,236
43,507
37,449
16,564
40,911
12,477
17,837
9,325
9,630
17,111
12,867
9,774
73,506
102,174
83,109
71,722
59,172
67,142
58,169
50,708
60,873
54,128
60,715
73,981
83,391
49,985
51,811
51,81149,98583,39173,98160,71554,12860,87350,70858,16967,14259,17271,72283,109102,17473,5069,77412,86717,1119,6309,32517,83712,47740,91116,56437,44943,50732,23639,21518,78023,89965,06465,064055,23639,76039,76024,00654,1046,6366,6367,8078,3362,7422,74204,7553,4563,4566,72911,5848,1848,1843,9093,5708,7168,7164,7847,20527,02127,02128,40522,70126,31326,31329,53836,82051,82751,8275645,5441,0181,0181,6069144,5914,591100,850100,850109,617109,61722,07611,64914,52714,52714,62305,3095,30900010,1370005,2100007,277006,0003,80000015,500001,200
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
108,418
0
0
0
100,783
100,783
101,680
87,812
82,756
82,756
63,598
66,015
10,944
10,944
10,145
11,218
14,749
14,749
11,787
4,414
10,057
10,057
37,862
44,026
35,352
35,352
30,155
28,132
23,160
23,160
21,395
22,728
21,035
21,035
15,686
0
6,413
6,413
1,387
1,473
401
401
23,753
52,496
53,074
53,074
60,884
0
79,738
79,738
130,964
130,887
114,980
146,978
130,290
78,161
77,511
157,269
134,629
107,425
90,590
70,221
62,151
59,587
54,384
39,977
136,380
148,467
149,680
145,803
135,701
122,924
106,513
62,608
49,993
45,760
22,518
17,532
110,525
101,368
101,368110,52517,53222,51845,76049,99362,608106,513122,924135,701145,803149,680148,467136,38039,97754,38459,58762,15170,22190,590107,425134,629157,26977,51178,161130,290146,978114,980130,887130,96479,73879,738060,88453,07453,07452,49623,7534014011,4731,3876,4136,413015,68621,03521,03522,72821,39523,16023,16028,13230,15535,35235,35244,02637,86210,05710,0574,41411,78714,74914,74911,21810,14510,94410,94466,01563,59882,75682,75687,812101,680100,783100,783000108,4180000000000000000000000000000000
       Net Receivables 
500
0
0
1,000
0
0
0
3,300
1,300
0
0
3,195
0
0
0
1,611
0
0
0
2,641
0
0
0
7,596
7,596
0
2,938
3,462
3,462
6,008
4,347
8,367
8,367
5,212
5,212
8,203
8,203
7,255
6,238
2,583
2,583
5,928
7,767
8,988
8,988
7,553
13,052
12,139
12,139
12,015
12,465
18,093
18,093
8,686
15,234
18,075
18,075
8,302
12,580
9,784
9,784
5,875
6,282
7,844
7,844
5,570
0
13,109
13,109
21,583
17,826
21,032
21,032
18,869
12,893
8,688
8,688
5,107
0
13,985
9,360
9,488
15,395
17,839
15,310
19,285
25,725
14,764
18,229
16,696
11,447
13,912
14,138
12,110
8,725
10,388
11,425
33,607
46,754
3,326
30,451
21,692
21,282
2,443
31,509
17,231
2,158
2,248
2,283
2,749
6,239
6,2392,7492,2832,2482,15817,23131,5092,44321,28221,69230,4513,32646,75433,60711,42510,3888,72512,11014,13813,91211,44716,69618,22914,76425,72519,28515,31017,83915,3959,4889,36013,98505,1078,6888,68812,89318,86921,03221,03217,82621,58313,10913,10905,5707,8447,8446,2825,8759,7849,78412,5808,30218,07518,07515,2348,68618,09318,09312,46512,01512,13912,13913,0527,5538,9888,9887,7675,9282,5832,5836,2387,2558,2038,2035,2125,2128,3678,3674,3476,0083,4623,4622,93807,5967,5960002,6410001,6110003,195001,3003,3000001,00000500
       Inventory 
200
0
0
200
0
0
0
100
200
0
0
804
0
0
0
186
447
454
666
860
695
0
810
569
569
0
351
375
375
1,069
545
1,057
1,057
1,310
1,310
1,597
1,597
966
1,171
1,050
1,050
1,265
1,354
3,332
3,332
3,064
2,948
1,771
1,771
2,194
1,683
1,837
1,837
2,592
2,157
1,072
1,072
932
1,070
862
862
906
1,699
1,675
1,675
1,599
0
1,520
1,520
1,854
2,892
3,762
3,762
5,564
6,473
6,729
6,729
5,751
0
4,155
4,155
3,640
3,909
3,258
5,406
5,747
5,870
6,157
5,948
5,724
6,030
4,770
4,258
2,601
2,260
3,570
3,523
4,154
2,903
0
6,467
5,401
2,787
0
5,317
3,881
3,745
0
0
1,439
5,286
5,2861,439003,7453,8815,31702,7875,4016,46702,9034,1543,5233,5702,2602,6014,2584,7706,0305,7245,9486,1575,8705,7475,4063,2583,9093,6404,1554,15505,7516,7296,7296,4735,5643,7623,7622,8921,8541,5201,52001,5991,6751,6751,6999068628621,0709321,0721,0722,1572,5921,8371,8371,6832,1941,7711,7712,9483,0643,3323,3321,3541,2651,0501,0501,1719661,5971,5971,3101,3101,0571,0575451,069375375351056956981006958606664544471860008040020010000020000200
       Other Current Assets 
600
0
0
1,100
0
0
0
7,400
4,300
0
0
5,160
0
0
0
745
741
738
318
423
532
0
469
325
325
0
344
347
347
936
1,620
1,694
1,694
3,694
3,694
5,598
5,598
5,971
4,777
708
708
594
3,050
261
261
5,086
4,849
293
293
3,568
2,634
2,181
2,181
2,657
3,038
3,626
3,626
4,264
4,555
3,372
3,372
2,229
2,585
2,642
2,642
2,672
0
71
71
1,789
2,933
95
95
2,831
3,380
5
5
5,189
0
44,687
7,989
9,657
8,883
5,894
4,682
5,522
1,728
8,958
467
613
721
759
1,583
633
5,163
4,264
611
704
455
38,726
421
766
658
32,826
434
480
844
2,096
6,264
6,532
7,551
7,5516,5326,2642,09684448043432,82665876642138,7264557046114,2645,1636331,5837597216134678,9581,7285,5224,6825,8948,8839,6577,98944,68705,189553,3802,83195952,9331,789717102,6722,6422,6422,5852,2293,3723,3724,5554,2643,6263,6263,0382,6572,1812,1812,6343,5682932934,8495,0862612613,0505947087084,7775,9715,5985,5983,6943,6941,6941,6941,620936347347344032532546905324233187387417450005,160004,3007,4000001,10000600
   > Long-term Assets 
2,200
0
0
12,100
0
0
0
6,900
7,100
0
0
8,882
0
0
0
7,168
0
0
0
6,299
0
0
0
4,345
4,345
0
3,418
4,365
4,365
4,194
4,434
6,517
6,517
13,164
13,164
24,836
24,836
25,799
26,368
32,363
32,363
33,611
32,512
38,115
38,115
43,767
42,306
45,291
45,291
48,826
39,166
32,672
32,672
34,251
28,682
27,455
27,455
23,257
27,138
29,252
29,252
34,125
32,674
32,750
32,750
103,433
0
92,226
92,226
83,459
83,583
82,629
82,629
69,510
65,137
61,885
61,885
54,379
0
2,616
48,671
71,365
70,131
64,296
54,076
54,809
128,494
128,152
119,928
120,260
121,130
65,449
71,185
68,509
67,286
69,056
76,750
64,382
45,947
48,183
50,627
51,889
58,269
54,775
60,386
32,225
32,536
31,942
31,269
29,746
30,845
30,84529,74631,26931,94232,53632,22560,38654,77558,26951,88950,62748,18345,94764,38276,75069,05667,28668,50971,18565,449121,130120,260119,928128,152128,49454,80954,07664,29670,13171,36548,6712,616054,37961,88561,88565,13769,51082,62982,62983,58383,45992,22692,2260103,43332,75032,75032,67434,12529,25229,25227,13823,25727,45527,45528,68234,25132,67232,67239,16648,82645,29145,29142,30643,76738,11538,11532,51233,61132,36332,36326,36825,79924,83624,83613,16413,1646,5176,5174,4344,1944,3654,3653,41804,3454,3450006,2990007,1680008,882007,1006,90000012,100002,200
       Property Plant Equipment 
1,100
0
0
1,700
0
0
0
4,100
4,300
0
0
4,618
0
0
0
3,502
3,292
3,177
2,742
2,922
2,722
0
2,706
2,672
2,672
0
3,095
3,405
3,405
3,431
3,658
5,085
5,085
11,747
11,747
18,162
18,162
19,863
20,460
22,317
22,317
23,433
22,376
25,705
25,705
31,013
34,201
35,140
35,140
34,473
29,890
27,601
27,601
25,734
25,936
24,759
24,759
20,438
22,677
21,425
21,425
22,462
20,409
19,383
19,383
18,041
0
18,238
18,238
17,271
17,352
17,435
17,435
16,605
15,182
1,777
1,777
1,978
0
2,616
2,616
3,104
3,186
3,320
3,382
3,328
3,180
3,001
2,722
7,315
8,248
7,805
13,378
12,949
5,155
4,156
10,199
8,725
8,440
2,963
8,321
8,319
9,445
2,937
12,760
13,032
13,822
2,552
2,257
1,950
3,452
3,4521,9502,2572,55213,82213,03212,7602,9379,4458,3198,3212,9638,4408,72510,1994,1565,15512,94913,3787,8058,2487,3152,7223,0013,1803,3283,3823,3203,1863,1042,6162,61601,9781,7771,77715,18216,60517,43517,43517,35217,27118,23818,238018,04119,38319,38320,40922,46221,42521,42522,67720,43824,75924,75925,93625,73427,60127,60129,89034,47335,14035,14034,20131,01325,70525,70522,37623,43322,31722,31720,46019,86318,16218,16211,74711,7475,0855,0853,6583,4313,4053,4053,09502,6722,6722,70602,7222,9222,7423,1773,2923,5020004,618004,3004,1000001,700001,100
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,461
20,461
0
18,491
18,491
18,491
18,490
18,491
18,491
18,491
18,490
18,491
18,491
18,491
0
18,491
18,491
18,669
19,134
18,491
18,491
18,491
18,491
18,491
18,491
18,491
18,491
18,491
18,491
18,491
18,491
18,491
18,491
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,83616,83616,83616,83616,83616,83616,83616,83616,83616,83616,83616,83616,83616,83618,49118,49118,49118,49118,49118,49118,49118,49118,49118,49118,49118,49118,49118,49119,13418,66918,49118,491018,49118,49118,49118,49018,49118,49118,49118,49018,49118,49118,491020,46120,4610000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
300
0
0
200
0
0
0
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
49,250
49,089
0
41,589
41,589
41,259
41,094
40,139
40,139
34,264
31,326
28,390
28,390
22,108
0
15,825
15,825
29,209
25,508
22,837
22,274
21,709
94,256
92,289
72,571
70,962
69,339
1,629
1,428
1,224
1,019
813
610
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000006108131,0191,2241,4281,62969,33970,96272,57192,28994,25621,70922,27422,83725,50829,20915,82515,825022,10828,39028,39031,32634,26440,13940,13941,09441,25941,58941,589049,08949,2500000000000000000000000000000000000000000000000000000000010000020000300
       Long-term Assets Other 
800
0
0
10,200
0
0
0
2,700
2,800
0
0
4,264
0
0
0
3,666
0
0
0
3,377
0
0
0
1,673
1,673
0
323
960
960
763
776
1,432
1,432
1,417
1,417
6,674
6,674
5,936
5,908
10,046
10,046
10,178
10,136
12,410
12,410
12,754
8,105
10,151
10,151
14,353
9,276
5,071
5,071
8,517
2,746
2,696
2,696
2,819
4,461
7,827
7,827
11,663
12,265
13,203
13,203
15,669
0
13,908
13,908
6,438
6,647
6,564
6,564
150
139
125
125
117
0
158
158
4,968
6,820
7,531
101
8,242
1,910
9,099
10,163
6,077
5,944
5,746
5,604
5,463
34,927
39,274
1,825
1,757
1,584
24,939
1,377
1,267
-120,734
-95,639
2,212
2,357
1,878
12,554
12,176
10,960
10,557
10,55710,96012,17612,5541,8782,3572,212-95,639-120,7341,2671,37724,9391,5841,7571,82539,27434,9275,4635,6045,7465,9446,07710,1639,0991,9108,2421017,5316,8204,96815815801171251251391506,5646,5646,6476,43813,90813,908015,66913,20313,20312,26511,6637,8277,8274,4612,8192,6962,6962,7468,5175,0715,0719,27614,35310,15110,1518,10512,75412,41012,41010,13610,17810,04610,0465,9085,9366,6746,6741,4171,4171,4321,43277676396096032301,6731,6730003,3770003,6660004,264002,8002,70000010,20000800
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,342
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000010,34200000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
6,200
0
0
6,800
0
0
0
7,200
7,500
0
0
7,533
0
0
0
5,853
10,322
9,402
8,593
9,478
7,769
0
7,750
10,635
10,635
0
9,716
10,790
10,790
13,215
12,543
35,191
35,191
31,457
31,457
28,851
28,851
37,478
33,447
37,697
37,697
34,274
39,342
41,868
41,868
47,450
48,479
46,774
46,774
44,231
38,104
43,315
43,315
43,300
47,851
49,433
49,433
38,116
43,916
38,309
38,309
44,220
40,334
39,608
39,608
108,354
0
86,807
86,807
128,472
131,919
125,764
125,764
116,768
124,337
149,312
149,312
172,909
0
147,112
147,112
197,868
211,152
203,413
199,606
182,432
180,964
167,543
264,807
216,690
203,264
187,520
183,204
183,486
182,851
180,635
175,658
159,276
156,435
149,371
156,437
163,711
165,132
169,021
165,895
161,270
158,198
153,930
178,905
57,784
92,951
92,95157,784178,905153,930158,198161,270165,895169,021165,132163,711156,437149,371156,435159,276175,658180,635182,851183,486183,204187,520203,264216,690264,807167,543180,964182,432199,606203,413211,152197,868147,112147,1120172,909149,312149,312124,337116,768125,764125,764131,919128,47286,80786,8070108,35439,60839,60840,33444,22038,30938,30943,91638,11649,43349,43347,85143,30043,31543,31538,10444,23146,77446,77448,47947,45041,86841,86839,34234,27437,69737,69733,44737,47828,85128,85131,45731,45735,19135,19112,54313,21510,79010,7909,716010,63510,6357,75007,7699,4788,5939,40210,3225,8530007,533007,5007,2000006,800006,200
   > Total Current Liabilities 
4,400
0
0
4,800
0
0
0
4,100
4,500
0
0
4,353
0
0
0
3,495
8,155
7,305
6,739
6,113
5,001
0
4,901
6,461
6,461
0
5,509
6,509
6,509
7,796
7,868
17,868
17,868
18,980
18,980
23,326
23,326
30,490
21,580
24,896
24,896
19,266
20,015
21,314
21,314
25,024
27,024
24,955
24,955
22,305
18,548
20,255
20,255
16,204
21,484
22,896
22,896
18,478
24,362
19,421
19,421
18,910
17,642
18,314
18,314
16,244
0
14,359
14,359
17,102
33,607
40,595
40,595
37,841
47,720
70,842
70,842
52,749
0
48,788
48,788
58,188
59,185
62,421
84,049
88,709
97,308
86,176
87,185
51,613
47,019
38,383
31,358
33,580
31,763
35,984
32,336
27,018
23,009
15,109
9,120
16,280
17,587
21,000
44,023
46,217
41,511
55,793
79,361
51,502
54,054
54,05451,50279,36155,79341,51146,21744,02321,00017,58716,2809,12015,10923,00927,01832,33635,98431,76333,58031,35838,38347,01951,61387,18586,17697,30888,70984,04962,42159,18558,18848,78848,788052,74970,84270,84247,72037,84140,59540,59533,60717,10214,35914,359016,24418,31418,31417,64218,91019,42119,42124,36218,47822,89622,89621,48416,20420,25520,25518,54822,30524,95524,95527,02425,02421,31421,31420,01519,26624,89624,89621,58030,49023,32623,32618,98018,98017,86817,8687,8687,7966,5096,5095,50906,4616,4614,90105,0016,1136,7397,3058,1553,4950004,353004,5004,1000004,800004,400
       Short-term Debt 
200
0
0
400
0
0
0
400
400
0
0
397
0
0
0
538
0
0
0
643
0
0
0
781
781
0
677
922
922
289
241
257
257
231
231
552
552
369
571
828
828
795
795
420
420
336
301
980
980
931
805
753
753
754
749
895
895
764
2,192
2,376
2,376
2,374
2,225
2,123
2,123
2,056
0
3,428
3,428
6,875
20,447
19,279
19,279
18,124
27,888
42,345
42,345
37,803
0
434
434
283
286
268
272
291
301
111
114
108
107
106
1,086
1,104
1,631
645
604
563
520
474
484
494
504
900
27,101
27,173
27,310
38,628
21,386
21,634
22,103
22,10321,63421,38638,62827,31027,17327,1019005044944844745205636046451,6311,1041,086106107108114111301291272268286283434434037,80342,34542,34527,88818,12419,27919,27920,4476,8753,4283,42802,0562,1232,1232,2252,3742,3762,3762,19276489589574975475375380593198098030133642042079579582882857136955255223123125725724128992292267707817810006430005380003970040040000040000200
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
98,779
0
0
0
7,822
0
0
0
434
0
0
0
268
272
885
301
111
114
108
107
106
104
105
35
0
0
0
0
0
0
0
0
0
26,184
26,241
26,299
37,668
20,515
20,851
21,187
21,18720,85120,51537,66826,29926,24126,184000000000351051041061071081141113018852722680004340007,82200098,77900000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
2,000
0
0
3,100
0
0
0
2,500
2,800
0
0
2,598
0
0
0
1,519
0
1,544
1,481
1,540
1,487
0
1,182
1,205
1,205
0
1,064
1,322
1,322
2,388
2,357
4,397
4,397
6,961
6,961
9,660
9,660
15,486
11,069
11,497
11,497
7,400
6,941
9,702
9,702
13,071
12,933
8,568
8,568
7,303
4,912
5,760
5,760
4,272
4,899
6,366
6,366
5,262
5,156
4,941
4,941
3,982
3,432
3,920
3,920
4,758
0
3,596
3,596
3,268
4,115
5,099
5,099
6,167
7,007
8,024
8,024
11,403
0
18,047
10,565
7,043
8,966
7,105
7,962
12,321
8,564
7,478
15,906
11,169
11,399
3,503
4,150
4,798
3,538
6,100
6,790
4,879
2,660
2,934
2,824
5,116
6,874
7,679
6,048
7,318
2,479
7,890
10,023
11,786
13,263
13,26311,78610,0237,8902,4797,3186,0487,6796,8745,1162,8242,9342,6604,8796,7906,1003,5384,7984,1503,50311,39911,16915,9067,4788,56412,3217,9627,1058,9667,04310,56518,047011,4038,0248,0247,0076,1675,0995,0994,1153,2683,5963,59604,7583,9203,9203,4323,9824,9414,9415,1565,2626,3666,3664,8994,2725,7605,7604,9127,3038,5688,56812,93313,0719,7029,7026,9417,40011,49711,49711,06915,4869,6609,6606,9616,9614,3974,3972,3572,3881,3221,3221,06401,2051,2051,18201,4871,5401,4811,54401,5190002,598002,8002,5000003,100002,000
       Other Current Liabilities 
2,200
0
0
1,300
0
0
0
1,200
1,300
0
0
1,358
0
0
0
1,438
7,927
5,241
4,783
2,367
2,905
0
3,173
3,403
3,403
0
2,064
2,460
2,460
2,293
3,001
3,591
3,591
3,211
3,211
10,586
10,586
13,840
8,114
12,389
12,389
10,924
11,542
10,630
10,630
11,481
13,206
12,459
12,459
12,252
11,412
12,944
12,944
9,527
11,370
11,773
11,773
9,402
14,485
9,576
9,576
8,283
7,941
7,473
7,473
6,506
0
6,146
6,146
6,322
7,592
14,837
14,837
12,552
12,213
19,137
19,137
3,522
0
128,631
32,668
47,042
46,818
52,825
74,198
73,642
86,516
76,580
69,281
38,612
33,793
34,660
26,007
3,677
1,989
3,875
1,932
3,488
536
5,200
437
451
393
5,270
10,874
11,726
11,722
9,275
7,952
500
18,688
18,6885007,9529,27511,72211,72610,8745,2703934514375,2005363,4881,9323,8751,9893,67726,00734,66033,79338,61269,28176,58086,51673,64274,19852,82546,81847,04232,668128,63103,52219,13719,13712,21312,55214,83714,8377,5926,3226,1466,14606,5067,4737,4737,9418,2839,5769,57614,4859,40211,77311,77311,3709,52712,94412,94411,41212,25212,45912,45913,20611,48110,63010,63011,54210,92412,38912,3898,11413,84010,58610,5863,2113,2113,5913,5913,0012,2932,4602,4602,06403,4033,4033,17302,9052,3674,7835,2417,9271,4380001,358001,3001,2000001,300002,200
   > Long-term Liabilities 
1,800
0
0
2,000
0
0
0
3,100
3,000
0
0
3,180
0
0
0
2,358
0
0
0
3,365
0
0
0
4,174
4,174
0
4,207
4,281
4,281
5,419
4,675
17,323
17,323
12,477
12,477
5,525
5,525
6,988
11,867
12,801
12,801
15,008
19,327
20,554
20,554
22,426
21,455
21,819
21,819
21,926
19,556
23,060
23,060
27,096
26,367
26,537
26,537
19,638
19,554
18,888
18,888
25,310
22,692
21,294
21,294
92,110
0
72,448
72,448
111,370
98,312
85,169
85,169
78,927
76,617
78,470
78,470
120,160
0
0
98,324
139,680
151,967
140,992
115,557
93,723
83,656
81,367
177,622
165,077
156,245
149,137
151,846
149,906
151,088
144,651
143,322
132,258
133,426
134,262
147,317
147,431
147,545
148,021
121,872
115,053
116,687
98,137
99,544
6,282
38,897
38,8976,28299,54498,137116,687115,053121,872148,021147,545147,431147,317134,262133,426132,258143,322144,651151,088149,906151,846149,137156,245165,077177,62281,36783,65693,723115,557140,992151,967139,68098,32400120,16078,47078,47076,61778,92785,16985,16998,312111,37072,44872,448092,11021,29421,29422,69225,31018,88818,88819,55419,63826,53726,53726,36727,09623,06023,06019,55621,92621,81921,81921,45522,42620,55420,55419,32715,00812,80112,80111,8676,9885,5255,52512,47712,47717,32317,3234,6755,4194,2814,2814,20704,1744,1740003,3650002,3580003,180003,0003,1000002,000001,800
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
734
547
555
594
614
156
111,724
113,038
114,382
115,734
117,178
118,631
120,132
121,686
123,258
124,879
126,520
128,210
141,461
141,774
142,086
142,397
116,525
108,074
109,934
0
0
0
0
0000109,934108,074116,525142,397142,086141,774141,461128,210126,520124,879123,258121,686120,132118,631117,178115,734114,382113,038111,7241566145945555477340000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,342
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000010,34200000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
246
246
226
1,788
1,344
0
1,528
3,259
0
0
2,834
2,741
3,789
3,822
3,088
15,387
0
10,484
2,077
3,147
3,023
4,544
7,974
9,838
10,615
12,241
16,672
17,487
17,666
19,403
18,341
19,375
19,683
19,233
17,119
20,695
20,421
24,741
23,902
23,527
19,041
16,783
17,730
17,208
0
0
0
19,354
0
23,329
0
12,200
23,974
24,360
25,123
9,827
9,626
9,456
8,554
2,333
2,094
2,206
0
96,289
120,151
138,892
151,233
140,445
115,002
93,129
83,042
81,002
65,898
52,039
41,863
43,378
30,779
27,658
28,090
20,646
17,859
5,292
4,938
4,212
4,139
4,068
3,999
3,917
3,847
5,716
5,727
0
0
0
0
00005,7275,7163,8473,9173,9994,0684,1394,2124,9385,29217,85920,64628,09027,65830,77943,37841,86352,03965,89881,00283,04293,129115,002140,445151,233138,892120,15196,28902,2062,0942,3338,5549,4569,6269,82725,12324,36023,97412,200023,329019,35400017,20817,73016,78319,04123,52723,90224,74120,42120,69517,11919,23319,68319,37518,34119,40317,66617,48716,67212,24110,6159,8387,9744,5443,0233,1472,07710,484015,3873,0883,8223,7892,7412,834003,2591,52801,3441,7882262462460000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,102
0
0
0
11,581
0
0
0
10,342
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000010,34200011,58100013,102000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
-1,500
0
0
23,100
0
0
0
14,300
11,400
0
0
17,785
0
0
0
9,067
2,543
13,729
11,938
10,882
9,607
0
7,848
7,509
7,509
0
11,958
12,286
12,286
10,641
20,479
92,061
92,061
92,773
92,773
116,757
116,757
105,107
94,525
86,654
86,654
79,374
71,920
73,026
73,026
58,985
55,432
54,627
54,627
56,860
50,663
48,546
48,546
49,953
50,070
44,863
44,863
32,364
33,468
36,305
36,305
31,894
32,363
29,794
29,794
25,361
0
30,504
30,504
-10,064
-15,405
-9,512
-9,512
57,863
40,048
24,895
24,895
13,637
0
67,865
67,865
51,145
36,833
42,069
59,082
76,728
96,463
84,563
87,054
78,546
65,742
2,780
-9,582
-17,777
-26,963
-29,199
32,067
182,125
171,200
162,266
136,504
118,880
98,957
78,244
55,232
-3,332
-12,440
-21,145
-38,166
143,192
110,149
110,149143,192-38,166-21,145-12,440-3,33255,23278,24498,957118,880136,504162,266171,200182,12532,067-29,199-26,963-17,777-9,5822,78065,74278,54687,05484,56396,46376,72859,08242,06936,83351,14567,86567,865013,63724,89524,89540,04857,863-9,512-9,512-15,405-10,06430,50430,504025,36129,79429,79432,36331,89436,30536,30533,46832,36444,86344,86350,07049,95348,54648,54650,66356,86054,62754,62755,43258,98573,02673,02671,92079,37486,65486,65494,525105,107116,757116,75792,77392,77392,06192,06120,47910,64112,28612,28611,95807,5097,5097,84809,60710,88211,93813,7292,5439,06700017,7850011,40014,30000023,10000-1,500
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
1,984
0
0
0
1,984
1,988
2,366
2,366
2,366
2,366
0
2,366
2,366
2,366
0
2,366
2,366
2,366
2,384
2,779
3,081
3,081
3,088
3,088
3,135
3,135
3,398
3,427
3,436
3,436
3,452
3,452
3,480
3,480
3,488
3,488
3,490
3,490
3,493
3,500
3,516
3,516
3,519
3,519
3,540
3,540
3,553
3,553
3,589
3,589
3,589
3,589
3,641
3,641
3,673
0
3,714
3,714
3,722
3,722
3,746
3,746
5,933
5,998
6,188
6,188
6,229
0
6,331
6,331
6,331
6,331
414
414
414
414
414
420
421
424
427
427
427
428
429
518
635
582
583
584
584
586
586
590
590
608
628
644
893
893
8938936446286085905905865865845845835826355184294284274274274244214204144144144144146,3316,3316,3316,33106,2296,1886,1885,9985,9333,7463,7463,7223,7223,7143,71403,6733,6413,6413,5893,5893,5893,5893,5533,5533,5403,5403,5193,5193,5163,5163,5003,4933,4903,4903,4883,4883,4803,4803,4523,4523,4363,4363,4273,3983,1353,1353,0883,0883,0813,0812,7792,3842,3662,3662,36602,3662,3662,36602,3662,3662,3662,3661,9881,9840001,98400000000000
   Retained Earnings -716,710-680,436-616,004-585,220-557,770-537,624-474,180-447,756-425,455-403,453-383,872-384,187-372,909-361,206-392,080-391,215-388,476-379,612-371,007-357,989-294,130-278,359-274,921-263,702-254,440-276,119-305,046-319,800-326,837-305,233-279,793-279,7930-326,205-320,452-320,452-293,303-283,257-235,546-235,546-240,668-234,304-192,621-192,6210-195,298-189,393-189,393-187,302-189,005-180,619-180,619-183,297-179,958-171,644-171,644-165,947-162,565-160,205-160,205-157,479-155,175-148,121-148,121-142,184-133,078-110,384-110,384-104,527-94,312-75,183-75,183-68,735-56,851-47,806-47,806-57,133-57,133-59,875-59,875-61,573-59,704-56,381-56,381-56,0540-59,386-59,386000-56,512000-47,051000-40,35700-35,000-32,500000-25,70000-20,300
   Accumulated Other Comprehensive Income 
-5,300
0
0
-5,700
0
0
0
-5,500
-5,500
0
0
-3,212
0
0
0
-5,172
0
0
0
-6,149
0
0
0
-6,648
-6,648
0
-5,532
-4,877
-4,877
-3,893
-2,936
1,176
1,176
-1,201
-1,201
13,039
13,039
-804
-834
-2,719
-2,719
3,576
3,404
6,451
6,451
8,383
11,372
14,085
14,085
18,686
13,556
12,150
12,150
13,137
15,042
14,469
14,469
8,192
11,641
10,873
10,873
13,584
11,379
10,057
10,057
9,384
0
10,253
10,253
10,112
10,539
10,815
10,815
8,790
-2,324
-7,423
-7,423
-18,810
0
-23,000
-22,657
-18,850
-17,385
-23,565
-23,391
-22,680
-23,421
-23,266
-23,255
-23,659
-23,651
-23,416
-23,203
-22,848
-22,972
-22,806
-23,627
-22,518
-21,918
-21,051
-22,306
-22,350
-22,744
-23,940
-25,042
-26,328
-27,909
-26,341
-26,026
-25,943
-25,951
-25,951-25,943-26,026-26,341-27,909-26,328-25,042-23,940-22,744-22,350-22,306-21,051-21,918-22,518-23,627-22,806-22,972-22,848-23,203-23,416-23,651-23,659-23,255-23,266-23,421-22,680-23,391-23,565-17,385-18,850-22,657-23,0000-18,810-7,423-7,423-2,3248,79010,81510,81510,53910,11210,25310,25309,38410,05710,05711,37913,58410,87310,87311,6418,19214,46914,46915,04213,13712,15012,15013,55618,68614,08514,08511,3728,3836,4516,4513,4043,576-2,719-2,719-834-80413,03913,039-1,201-1,2011,1761,176-2,936-3,893-4,877-4,877-5,5320-6,648-6,648000-6,149000-5,172000-3,21200-5,500-5,500000-5,70000-5,300
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
363,984
366,459
368,897
374,724
385,020
387,105
389,451
391,416
393,478
427,383
430,141
433,097
433,756
434,199
434,254
434,055
434,391
497,249
615,207
565,440
566,916
542,093
544,094
546,565
549,349
553,859
560,025
572,626
0
0
0
0
0000572,626560,025553,859549,349546,565544,094542,093566,916565,440615,207497,249434,391434,055434,254434,199433,756433,097430,141427,383393,478391,416389,451387,105385,020374,724368,897366,459363,9840000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000-49,998-49,998-49,998-49,998-49,998-49,998-49,998-49,998-49,998-42,573-22,361-17,506-14,3380000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
24,100
0
0
54,500
0
0
0
52,300
51,900
0
0
62,965
0
0
0
61,096
0
0
0
72,542
0
0
0
64,529
64,529
0
65,646
71,178
71,178
71,854
82,209
147,679
147,679
148,019
148,019
148,389
148,389
159,364
160,667
161,120
161,120
166,658
169,591
173,479
173,479
180,192
182,756
185,173
185,173
189,856
191,086
193,085
193,085
195,862
197,456
198,498
198,498
200,577
201,571
202,462
202,462
203,726
204,697
205,489
205,489
207,602
0
209,158
209,158
210,406
211,002
211,473
211,473
326,397
329,677
346,582
346,582
352,423
0
-22,657
363,984
368,897
374,724
385,020
387,105
375,113
373,910
371,117
384,810
380,143
383,099
383,758
384,201
384,256
384,057
384,393
447,251
565,209
565,440
566,916
542,093
544,094
546,565
549,349
553,859
560,025
572,626
589,783
603,215
848,626
851,917
851,917848,626603,215589,783572,626560,025553,859549,349546,565544,094542,093566,916565,440565,209447,251384,393384,057384,256384,201383,758383,099380,143384,810371,117373,910375,113387,105385,020374,724368,897363,984-22,6570352,423346,582346,582329,677326,397211,473211,473211,002210,406209,158209,1580207,602205,489205,489204,697203,726202,462202,462201,571200,577198,498198,498197,456195,862193,085193,085191,086189,856185,173185,173182,756180,192173,479173,479169,591166,658161,120161,120160,667159,364148,389148,389148,019148,019147,679147,67982,20971,85471,17871,17865,646064,52964,52900072,54200061,09600062,9650051,90052,30000054,5000024,100



Balance Sheet

Currency in USD. All numbers in thousands.